Types of PAH
WHO group 1 |
(Idiopathic) Pulmonary Arterial Hypertension (PAH) |
WHO group 2 |
PAH due to left heart disease or hypoxemia |
WHO group 3 |
PAH due to chronic lung disease (e.g. COPD, ILD) |
WHO group 4 |
PAH due to chronic thromboembolic disease |
WHO group 5 |
PAH due to other causes
- hematologic (e.g. myelodysplastic syndromes)
- systemic (e.g. sarcoidosis)
- metabolic (e.g. glycogen storage disorders)
|
Symptoms
- dyspnea
- fatigue/weakness
- exertional angina
- syncope
- abdominal distension/pain
Signs
- left parasternal lift, prominent right ventricular heave
- pansystolic murmur of tricuspid regurgitation
- Signs of right heart failure
- JVD
- ascites
- peripheral edema
- hepatomegaly
- Loud P2
- Right-sided S3
Investigations
- Chest x-ray characteristically reveals bilateral pulmonary artery enlargement with attenuation of peripheral arteries
- Transthoracic echocardiography
- estimates pulmonary artery pressure
- evaluates for associated right ventricular dysfunction
- assesses for left ventricular dysfunction or valvular abnormality as a secondary cause of PAH (i.e. PAH group 2)
- Right heart catheterization
- is required for definitive diagnosis
- mean pulmonary arterial pressure >= 25 mm Hg
Treatment of group 1 PAH
- endothelin receptor antagonists (e.g. bosentan, ambrisetan)
- phosphodiesterase-5 inhibitors (e.g. sildenafil, tadalafil)
- prostacyclin pathway agonists (e.g. epoprostenol, treprostinil, iloprost)
- for patients with positive vasoreactive test during right heart catheterization: calcium channel blockers (e.g. long-acting nifedipine)
Acronyms
COPD=chronic obstructive pulmonary disease
ILD=interstitial lung disease
JVD=jugular venous distension